Media
News
Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray

JERSEY, Channel Islands, Feb.

Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call

JERSEY, Channel Islands, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2019, will be released before market open on Thursday, January 30, 2020.

Quotient Aims to Reduce Blood Testing Time

C’est une revolution dans l’univers de l’analyse de sang. Quotient, une société basée à Eysins (VD), aux portes de Nyon, met sur le marché une nouvelle technique qui permet d’obtenir des résultats complets d’un échantillon avec une grande rapidité.

CEO Franz Walt on CNN Money Switzerland

Swiss company taps into U.S. appetite for risk

Quotient at AABB 2019

Quotient is attending the 2019 AABB Annual Meeting in San Antonio, TX, from 19-22 October 2019.